arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Ironwood Pharmaceuticals, Inc.

IRWD Health Care Biotechnology: Pharmaceutical Preparations
$3.46
▼ -2.5% Today
as of Oct 23, 16:03 ET
Last 30 days -17.03% Sep 14 → Oct 23
$3.37 $3.68 $4.00 $4.31 $4.62 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$3.50
High
$3.60
Low
$3.49
Volume
$1M
Avg Vol
$3M
Mkt Cap
$621M
P/E (TTM)
6.36
Beta
—
52w High
$5.78
52w Low
$1.47
Div Yield
—
Shares Out
$165M

Recent Press Releases & News last 60 days · 5 items

Oct 16 · 11:55 MT Newswires
Ironwood Pharmaceuticals CEO Tom McCourt to Retire; Chief Commercial Officer Tammi Gaskins Named Successor
Oct 16 · 11:30 PR Business Wire
Ironwood Pharmaceuticals Appoints Tammi Gaskins as Chief Executive Officer
Oct 7 · 13:57 Zacks
Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?
▸ Show all 5 press releases & news Free account →

IRWD earnings at a glance

The options market is pricing a move of about ±67.2% after the report, a range of roughly $1.14 to $5.78 from today's $3.46. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±14.4% on average; after the most recent report on May 7, 2026 it moved -13.7%. That means options currently expect more movement than IRWD has typically delivered. IRWD beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 6%. The share price of $3.46 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.47
$5.78
46% of range
Avg surprise (last 4)
+257.4%
Avg reaction (last 2)
-14.4%
0% positive
Latest IV / EM
569%
EM ±67.2% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.14$-0.03$0.08$0.20$0.31 Actual $-0.14Est $-0.05Actual $0.14Est $-0.02Actual $0.24Est $0.09Actual $0.24Est $0.07Actual $0.31 Mar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-37M$2M$41M$80M$119M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.31 — — — — financials
Thu May 7, 2026Mar/2026 $0.24 $0.07 +242.9% +271.4% -13.7% earnings
Mon Nov 10, 2025Sep/2025 $0.24 $0.09 +166.7% — — earnings
Thu Aug 7, 2025Jun/2025 $0.14 $-0.02 +800.0% — — earnings
Wed May 7, 2025Mar/2025 $-0.14 $-0.05 -180.0% — -15.1% earnings

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$113M$107M——$85M$41M——
Cost of revenue————————
Gross profit————————
Operating income$79M$73M—$75M$45M$-29M—$26M
Net income$51M$41M——$24M$-37M——
EPS (diluted)$0.31$0.24——$0.14$-0.23——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$79M$220M$215M$140M$93M$108M$89M$88M
Inventory————————
Total current assets$199M$332M$274M$274M$192M$161M$182M$179M
Total assets$285M$435M$397M$396M$343M$327M$351M$390M
Long-term debt———$200M$199M$199M$199M$199M
Total liabilities$447M—$659M—————
Total equity$-162M$-217M$-262M$-264M$-308M$-334M$-301M$-311M

Implied volatility — last 90 days

23%373%723%1073%1423% Jun 07 — IV 393% · EM ±54.4%Jun 08 — IV 426% · EM ±56.2%Jun 09 — IV 438% · EM ±54.9%Jun 10 — IV 329% · EM ±38.8%Jun 11 — IV 524% · EM ±57.9%Jun 12 — IV 549% · EM ±56.2%Jun 15 — IV 976% · EM ±70.6%Jun 16 — IV 948% · EM ±56.0%Jun 17 — IV 1326% · EM ±55.4%Jun 19 — IV 169% · EM ±37.4%Jun 22 — IV 160% · EM ±33.4%Jun 23 — IV 292% · EM ±59.7%Jun 24 — IV 304% · EM ±60.9%Jun 25 — IV 292% · EM ±57.3%Jun 26 — IV 278% · EM ±53.1%Jun 29 — IV 223% · EM ±39.5%Jun 30 — IV 235% · EM ±40.5%Jul 01 — IV 262% · EM ±43.7%Jul 02 — IV 214% · EM ±34.6%Jul 03 — IV 222% · EM ±34.6%Jul 06 — IV 136% · EM ±18.8%Jul 07 — IV 24% · EM ±3.2%Jul 08 — IV 50% · EM ±6.3%Jul 09 — IV 36% · EM ±4.3%Jul 10 — IV 222% · EM ±24.5%Jul 13 — IV 412% · EM ±34.4%Jul 14 — IV 655% · EM ±47.4%Jul 15 — IV 847% · EM ±50.0%Jul 16 — IV 1423% · EM ±59.4%Jul 20 — IV 71% · EM ±16.9%Jul 21 — IV 95% · EM ±22.0%Jul 22 — IV 99% · EM ±22.6%Jul 23 — IV 88% · EM ±19.9%Jul 24 — IV 100% · EM ±22.0%Jul 27 — IV 101% · EM ±21.1%Jul 28 — IV 79% · EM ±16.1%Jul 29 — IV 122% · EM ±24.5%Jul 30 — IV 98% · EM ±19.2%Jul 31 — IV 83% · EM ±16.0%Aug 03 — IV 112% · EM ±19.8%Aug 04 — IV 109% · EM ±18.7%Aug 05 — IV 109% · EM ±18.2%Aug 06 — IV 87% · EM ±14.1%Aug 07 — IV 82% · EM ±12.9%Aug 10 — IV 71% · EM ±9.9%Aug 11 — IV 106% · EM ±14.0%Aug 12 — IV 106% · EM ±13.2%Aug 13 — IV 78% · EM ±9.2%Aug 14 — IV 100% · EM ±11.1%Aug 17 — IV 192% · EM ±16.1%Aug 18 — IV 176% · EM ±12.8%Aug 19 — IV 291% · EM ±17.2%Aug 20 — IV 318% · EM ±13.3%Aug 28 — IV 120% · EM ±23.0%Aug 31 — IV 128% · EM ±22.7%Sep 01 — IV 197% · EM ±33.9%Sep 02 — IV 182% · EM ±30.4%Sep 03 — IV 216% · EM ±35.0%Sep 04 — IV 240% · EM ±37.6%Sep 07 — IV 271% · EM ±37.6%Sep 08 — IV 281% · EM ±37.2%Sep 09 — IV 363% · EM ±45.5%Sep 10 — IV 440% · EM ±52.0%Sep 11 — IV 444% · EM ±49.0%Sep 14 — IV 502% · EM ±42.0%Sep 15 — IV 579% · EM ±41.9%Sep 16 — IV 648% · EM ±38.3%Sep 17 — IV 839% · EM ±35.0%Sep 21 — IV 163% · EM ±34.0%Sep 22 — IV 94% · EM ±19.3%Sep 23 — IV 102% · EM ±20.5%Sep 24 — IV 207% · EM ±40.6%Sep 25 — IV 117% · EM ±22.4%Sep 28 — IV 274% · EM ±48.5%Sep 29 — IV 136% · EM ±23.4%Sep 30 — IV 286% · EM ±47.9%Oct 01 — IV 479% · EM ±77.5%Oct 02 — IV 387% · EM ±60.4%Oct 06 — IV 448% · EM ±59.2%Oct 07 — IV 468% · EM ±58.7%Oct 08 — IV 569% · EM ±67.2%

Sector peers

CLYM
Climb Bio, Inc.
$615M $10.19-6.3%
NVCT
Nuvectis Pharma, Inc.
$662M $20.05-3.1%
SGMT
Sagimet Biosciences Inc.
$577M $9.58-4.1%
MDXG
MiMedx Group, Inc
$672M $3.91+4.5%
STTK
Shattuck Labs, Inc.
$568M $5.49-1.6%
CTMX
CytomX Therapeutics, Inc.
$556M $2.32-3.3%

IRWD earnings FAQ

What is IRWD's expected move for earnings?

Options currently price a move of about ±67.2%, or $2.32 per share either way from $3.46.

How does IRWD stock usually react to earnings?

Across the last 2 reports the average next-day move was ±14.4%, up 0 times and down 2 times.

What is IRWD's implied volatility?

IRWD's at-the-money implied volatility is about 6% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in